1,497
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Effects of Tiaopi Xiezhuo decoction on constipation and gut dysbiosis in patients with peritoneal dialysis

, , , , , , , , , & ORCID Icon show all
Pages 531-540 | Received 18 Apr 2022, Accepted 12 Mar 2023, Published online: 30 Mar 2023

References

  • Cano AE, Neil AK, Kang JY, Barnabas A, Eastwood JB, Nelson SR, Hartley I, Maxwell D. 2007. Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis. Am J Gastroenterol. 102(9):1990–1997.
  • Cho Y, Johnson DW. 2014. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis. 64(2):278–289.
  • Choi VM, Herrou J, Hecht AL, Teoh WP, Turner JR, Crosson S, Bubeck Wardenburg J. 2016. Activation of Bacteroides fragilis toxin by a novel bacterial protease contributes to anaerobic sepsis in mice. Nat Med. 22:563–567.
  • Feng X, Yan D, Zhao KJ, Luo JY, Ren YS, Kong WJ, Han YM, Xiao XH. 2011. Applications of microcalorimetry in the antibacterial activity evaluation of various Rhizoma coptidis. Pharm Biol. 49:348–353.
  • Feng X, Yang X, Yi C, Guo Q, Mao H, Jiang Z, Li Z, Chen D, Cui Y, Yu X. 2014. Escherichia coli peritonitis in peritoneal dialysis: the prevalence, antibiotic resistance and clinical outcomes in a South China dialysis center. Perit Dial Int. 34:308–316.
  • Flint HJ, Bayer EA, Rincon MT, Lamed R, White BA. 2008. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol. 6:121–131.
  • Habtemariam S. 2020. Berberine pharmacology and the gut microbiota: a hidden therapeutic link. Pharmacol Res. 155:104722.
  • Ji C, Deng Y, Yang A, Lu Z, Chen Y, Liu X, Han L, Zou C. 2020. Rhubarb enema improved colon mucosal barrier injury in 5/6 nephrectomy rats may associate with gut microbiota modification. Front Pharmacol. 11:1092.
  • Jiang N, Zhang C, Feng H, Yuan J, Ding L, Fang W, Gu A, Huang J, Li N, Gu L, et al. 2021. Clinical characteristics associated with the properties of gut microbiota in peritoneal dialysis patients. Perit Dial Int. 41:298–306.
  • Khalif IL, Quigley EM, Konovitch EA, Maximova ID. 2005. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis. 37(11):838–849.
  • Kim D, Kim WU. 2016. Editorial: can Prevotella copri be a causative pathobiont in rheumatoid arthritis? Arthritis Rheumatol. 68(11):2565–2567.
  • Koh A, De Vadder F, Kovatcheva-Datchary P, Backhed F. 2016. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 165(6):1332–1345.
  • Kosmadakis G, Albaret J, da Costa Correia E, Somda F, Aguilera D. 2018. Gastrointestinal disorders in peritoneal dialysis patients. Am J Nephrol. 48:319–325.
  • Kosmadakis G, Albaret J, Da Costa Correia E, Somda F, Aguilera D. 2019. Constipation in peritoneal dialysis patients. Perit Dial Int. 39:399–404.
  • Kovatcheva-Datchary P, Nilsson A, Akrami R, Lee YS, De Vadder F, Arora T, Hallen A, Martens E, Bjorck I, Backhed F. 2015. Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. Cell Metab. 22:971–982.
  • Ley RE. 2016. Gut microbiota in 2015: prevotella in the gut: choose carefully. Nat Rev Gastroenterol Hepatol. 13:69–70.
  • Li P, Kawachi H, Morioka T, Orikasa M, Oite T, Shi ZS, Shimizu F. 1997. Suppressive effects of sairei-to on monoclonal antibody 1-22-3-induced glomerulonephritis: analysis of effective components. Pathol Int. 47(7):430–435.
  • Liang JY, Zheng TT, Wu JF, Xie XN, Lu FH, Liu XS, Peng Y. 2020. A randomized controlled trial of Professor Huang Chunlin’s prescription for regulating spleen and relieving turbid to improve gastrointestinal function in peritoneal dialysis patients. Modernization of Traditional Chinese Medicine and Materia Materia-World Science and Technology. 22:498–503.
  • Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. 2006. Functional bowel disorders. Gastroenterology. 130(5):1480–1491.
  • Lu Z, Ji C, Luo X, Lan Y, Han L, Chen Y, Liu X, Lin Q, Lu F, Wu X, et al. 2020. Nanoparticle-mediated delivery of emodin via colonic irrigation attenuates renal injury in 5/6 nephrectomized rats. Front Pharmacol. 11:606227.
  • Luo D, Zhao W, Lin Z, Wu J, Lin H, Li Y, Song J, Zhang J, Peng H. 2021. The effects of hemodialysis and peritoneal dialysis on the gut microbiota of end-stage renal disease patients, and the relationship between gut microbiota and patient prognoses. Front Cell Infect Microbiol. 11:579386.
  • Lyu Y, Lin L, Xie Y, Li D, Xiao M, Zhang Y, Cheung SCK, Shaw PC, Yang X, Chan PKS, et al. 2021. Blood-glucose-lowering effect of Coptidis Rhizoma extracts from different origins via gut microbiota modulation in db/db mice. Front Pharmacol. 12:684358.
  • Martinez I, Stegen JC, Maldonado-Gomez MX, Eren AM, Siba PM, Greenhill AR, Walter J. 2015. The gut microbiota of rural Papua New Guineans: composition, diversity patterns, and ecological processes. Cell Rep. 11:527–538.
  • Morotomi M, Nagai F, Sakon H, Tanaka R. 2009. Paraprevotella clara gen. nov., sp. nov. and Paraprevotella xylaniphila sp. nov., members of the family 'Prevotellaceae’ isolated from human faeces. Int J Syst Evol Microbiol. 59(Pt 8):1895–1900.
  • Ohkusa T, Koido S, Nishikawa Y, Sato N. 2019. Gut microbiota and chronic constipation: a review and update. Front Med. 6:19.
  • Park M, Bae J, Lee DS. 2008. Antibacterial activity of [10]-gingerol and [12]-gingerol isolated from ginger rhizome against periodontal bacteria. Phytother Res. 22:1446–1449.
  • Ren Y, Wang D, Lu F, Zou X, Xu L, Wang K, Huang W, Su H, Zhang C, Gao Y, et al. 2018. Coptidis Rhizoma inhibits NLRP3 inflammasome activation and alleviates renal damage in early obesity-related glomerulopathy. Phytomedicine. 49:52–65.
  • Rondeau MP, Meltzer K, Michel KE, McManus CM, Washabau RJ. 2003. Short chain fatty acids stimulate feline colonic smooth muscle contraction. J Feline Med Surg. 5:167–173.
  • Scheiman J, Luber JM, Chavkin TA, MacDonald T, Tung A, Pham LD, Wibowo MC, Wurth RC, Punthambaker S, Tierney BT, et al. 2019. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat Med. 25:1104–1109.
  • Stadlbauer V, Horvath A, Ribitsch W, Schmerbock B, Schilcher G, Lemesch S, Stiegler P, Rosenkranz AR, Fickert P, Leber B. 2017. Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis. Sci Rep. 7(1):15601.
  • Svedlund J, Sjodin I, Dotevall G. 1988. GSRS–a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 33(2):129–134.
  • Tao Y, Li W, Liang W, Van Breemen RB. 2009. Identification and quantification of gingerols and related compounds in ginger dietary supplements using high-performance liquid chromatography-tandem mass spectrometry. J Agric Food Chem. 57(21):10014–10021.
  • Teitelbaum I. 2021. Peritoneal dialysis. N Engl J Med. 385(19):1786–1795.
  • Thompson J, Nguyen NY, Robrish SA. 1992. Sucrose fermentation by Fusobacterium mortiferum ATCC 25557: transport, catabolism, and products. J Bacteriol. 174(10):3227–3235.
  • Vacca M, Celano G, Calabrese FM, Portincasa P, Gobbetti M, De Angelis M. 2020. The controversial role of human gut Lachnospiraceae. Microorganisms. 8:537.
  • Valdes-Sotomayor J, Cirugeda A, Bajo MA, del Peso G, Escudero E, Sanchez-Tomero JA, Selgas R, Grupo de Estudios Peritoneales de M. 2003. Increased severity of Escherichia coli peritonitis in peritoneal dialysis patients independent of changes in in vitro antimicrobial susceptibility testing. Perit Dial Int. 23:450–455.
  • Valguarnera E, Wardenburg JB. 2020. Good gone bad: one toxin away from disease for Bacteroides fragilis. J Mol Biol. 432:765–785.
  • Wong RW, Hagg U, Samaranayake L, Yuen MK, Seneviratne CJ, Kao R. 2010. Antimicrobial activity of Chinese medicine herbs against common bacteria in oral biofilm. A Pilot Study. Int J Oral Maxillofac Surg. 39:599–605.
  • Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, et al. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science. 334:105–108.
  • Wu JS, Liu Y, Shi R, Lu X, Ma YM, Cheng NN. 2014. Effects of combinations of Xiexin decoction constituents on diabetic nephropathy in rats. J Ethnopharmacol. 157:126–133.
  • Xiao Y, Liu Y, Lai Z, Huang J, Li C, Zhang Y, Gong X, Deng J, Ye X, Li X. 2021. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy. J Ethnopharmacol. 270:113806.
  • Yacoub R, Nugent M, Cai W, Nadkarni GN, Chaves LD, Abyad S, Honan AM, Thomas SA, Zheng W, Valiyaparambil SA, et al. 2017. Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial. PLoS One. 12(9):e0184789.
  • Yajima T. 1985. Contractile effect of short-chain fatty acids on the isolated colon of the rat. J Physiol. 368:667–678.
  • Zhu L, Liu W, Alkhouri R, Baker RD, Bard JE, Quigley EM, Baker SS. 2014. Structural changes in the gut microbiome of constipated patients. Physiol Genomics. 46(18):679–686.
  • Zoppi G, Cinquetti M, Luciano A, Benini A, Muner A, Bertazzoni Minelli E. 1998. The intestinal ecosystem in chronic functional constipation. Acta Paediatr. 87:836–841.